Nautilus Biotechnology, Inc. (NAUT)
2.06
-0.16
(-7.21%)
USD |
NASDAQ |
Jan 09, 16:00
2.06
0.00 (0.00%)
After-Hours: 20:00
Nautilus Biotechnology Market Cap: 260.19M for Jan. 9, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Sensus Healthcare, Inc. | 78.18M |
| GoodRx Holdings, Inc. | 950.41M |
| Prelude Therapeutics, Inc. | 165.34M |
| ProKidney Corp. | 331.22M |
| Neumora Therapeutics, Inc. | 370.94M |
Market Cap Related Metrics
| Price to Book Value | 1.538 |
| Price | 2.06 |
| Earnings Yield | -24.18% |